Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2– advanced/metastatic breast cancer: results from a Phase Ib clinical trial. (European Journal of Cancer 2014, 50(suppl 6): p163)
Refereed conference paper presented and published in conference proceedings

香港中文大學研究人員

其它資訊
著者BARDIA A, CHAVEZ-MACGREGOR M, MODI S, CAMPONE M, MA Buig Yue Brigette, KITTANEH M, DIRIX D, MOTTA M, ZHANG V, BHANSALI S, FJAELLSKOG M, OLIVEIRA M
會議名稱26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
會議開始日18.11.2014
會議國家/地區西班牙
會議論文集題名26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
詳細描述organized by European Cancer Organisation,
出版年份2014
月份11
日期18
出版地Spain
語言英式英語
關鍵詞everolimus; metastatic breast cancer

上次更新時間 2018-24-01 於 13:35